Lestaurtinib
| 220px | |
| Lestaurtinib
| |
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C26H21N3O4 |
| Mol. mass | 439.462 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
|
WikiDoc Resources for Lestaurtinib | |
|
Articles | |
|---|---|
|
Most recent articles on Lestaurtinib Most cited articles on Lestaurtinib | |
|
Media | |
|
Powerpoint slides on Lestaurtinib | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Lestaurtinib at Clinical Trials.gov Clinical Trials on Lestaurtinib at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Lestaurtinib
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Lestaurtinib Discussion groups on Lestaurtinib Patient Handouts on Lestaurtinib Directions to Hospitals Treating Lestaurtinib Risk calculators and risk factors for Lestaurtinib
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Lestaurtinib | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Overview
Lestaurtinib (rINN, codenamed CEP-701) is a tyrosine kinase inhibitor undergoing research for the treatment of acute myelogenous leukemia (AML) and myeloproliferative disorders. It is an analog of staurosporine.
As of 2008, it is currently in Phase III clinical trials for AML and Phase II clinical trials for myeloproliferative disorders. [1]
It is being developed by Cephalon.
References
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
